This is also the type of event where you may see casual...

This is also the type of event where you may see casual conversations of takeovers and other M&A taking place. After all, we will be surrounded by all the companies that would be interested in taking EYE over. If Tom is attending it may be because someone at J&J, Alcon or Bausch + Lomb (all have booths near EYE) are keen on having a conversation. Not something I want to see right now as I would prefer to let iTrack Advance reach its full potential before the company considers any M&A options, but a rejected bid announced to the market is always a good catalyst for a run... In 2022 the M&A market for MIGS devices was incredibly active with enormous valuations being given to these devices, with the recent LCD news and other recent bullish changes to reimbursement favouring canaloplasty over stents, I wouldn't be surprised if it heats up again.

That is something to consider about these conferences though. They are not solely for selling devices to doctors. They also provide a venue where companies and investors can meet and converse with one another in a casual but still professional setting. I know many fund managers tend to attend conferences like this, and of course as we can see all the major healthcare companies involved in the ophthalmology space will also be attending.